Trial intelligence / Profile preview

Baclofen and Strength Training for Spastic Diplegic Cerebral Palsy

NCT00255073Phase 2Completed

Sponsor
University of Southern California
Start
Jan 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of baclofen in spastic diplegic cerebral palsy (SDCP), sponsored by University of Southern California. Started Jan 2005; status: completed.

02

Drugs

baclofen
03

Conditions

spastic diplegic cerebral palsy (SDCP)

Beyond the preview

Go deeper on NCT00255073.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00255073.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call